Huize (HUIZ) Competitors

NeueHealth (NYSE:NEUE) and Huize (NASDAQ:HUIZ) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, community ranking, institutional ownership, valuation, risk, analyst recommendations and earnings.

Is NEUE or HUIZ more profitable?

Huize has a net margin of 1.75% compared to NeueHealth's net margin of -36.28%. Huize's return on equity of 5.07% beat NeueHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeueHealth	-36.28%	-6.40%	8.45%
Huize	1.75%	5.07%	2.16%

Which has better valuation & earnings, NEUE or HUIZ?

Huize has higher revenue and earnings than NeueHealth. Huize is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeueHealth	$936.66M	0.06	-$1.15B	-$22.63	-0.30
Huize	$1.25B	0.02	$9.89M	-$0.20	-10.20

Does the MarketBeat Community prefer NEUE or HUIZ?

Huize received 6 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 50.00% of users gave Huize an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.

Company	Underperform	Outperform
NeueHealth	Outperform Votes No Votes	Underperform Votes 2 100.00%
Huize	Outperform Votes 6 50.00%	Underperform Votes 6 50.00%

Do institutionals and insiders believe in NEUE or HUIZ?

63.9% of NeueHealth shares are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 30.4% of Huize shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts rate NEUE or HUIZ?

NeueHealth currently has a consensus price target of $7.00, indicating a potential upside of 1.89%. Given NeueHealth's stronger consensus rating and higher probable upside, equities analysts clearly believe NeueHealth is more favorable than Huize.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Huize	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more risk and volatility, NEUE or HUIZ?

NeueHealth has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, Huize has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

Does the media refer more to NEUE or HUIZ?

In the previous week, Huize had 1 more articles in the media than NeueHealth. MarketBeat recorded 4 mentions for Huize and 3 mentions for NeueHealth. NeueHealth's average media sentiment score of 0.72 beat Huize's score of 0.49 indicating that NeueHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeueHealth	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Huize	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Huize beats NeueHealth on 9 of the 17 factors compared between the two stocks.